Teladoc Health Cash Flow Statement
NYSE: TDOCHealth CareMedical/Nursing ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Teladoc Health free cash flow
In fiscal 2025, Teladoc Health generated $294.4 million of operating cash flow and spent $8.9 million on capital expenditures. That left free cash flow of $285.5 million, a free-cash-flow margin of 11.3% of revenue. Free cash flow was up 0.9% from the prior year's $282.9 million.
Summary generated from market data by MetaCap's automated system. Methodology
Teladoc Health cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -200.32M | -1.00B | -220.37M | -13.66B | -428.79M | -485.14M | -98.86M | -97.08M | -106.78M | -74.22M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | — | — | — | 256.03M | 204.24M | 69.50M | 38.95M | 35.60M | 19.09M | 8.27M |
| Stock-Based Compensation | 80.41M | 145.95M | 201.55M | 217.85M | 302.59M | 475.53M | 66.70M | 43.77M | 30.60M | 7.72M |
| Change in Working Capital | 25.21M | -39.99M | -18.29M | -44.91M | -12.47M | -101.95M | -7.98M | -8.14M | -2.03M | -3.75M |
| Operating Cash Flow | 294.36M | 293.68M | 350.02M | 189.29M | 193.99M | -53.51M | 29.87M | -4.86M | -34.44M | -51.88M |
| Capital Expenditures | -8.89M | -10.79M | -11.46M | -16.48M | -8.53M | -4.02M | -3.51M | -4.01M | -2.63M | -2.11M |
| Investing Cash Flow | -266.00M | -124.05M | -156.35M | -167.74M | -72.98M | -590.98M | 25.01M | -257.50M | -448.38M | 26.15M |
| Debt Issued | — | — | — | — | — | — | — | 10.00K | 166.68M | 34.99M |
| Debt Repaid | — | — | — | — | — | — | 0 | 0 | -226.44M | -17.17M |
| Financing Cash Flow | -551.65M | 8.31M | 10.85M | 6.50M | 40.95M | 859.14M | 35.09M | 645.61M | 475.43M | 20.68M |
| Net Change in Cash | -523.30M | 177.94M | 204.53M | 28.05M | 161.96M | 214.65M | 89.98M | 383.26M | -7.39M | — |
| Free Cash Flow | 285.46M | 282.89M | 338.56M | 172.81M | 185.46M | -57.53M | 26.36M | -8.87M | -37.07M | -53.98M |
This table shows 10 annual periods of Teladoc Health's cash flow statement, from FY 2025 back to FY 2016, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow TDOC's reporting calendar. What is a cash flow statement?